Multidrug-resistant tuberculosis in the end tuberculosis era
Multidrug-resistant (MDR) tuberculosis (TB) emerged shortly after introduction of rifamycins in the 1960s; isoniazid resistance had already emerged by the mid-1950s. Without these two drugs, tuberculosis is very difficult and costly to treat, with unacceptably high rates of treatment failure, death...
Main Author: | J. Peter Cegielski |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Instituto Nacional de Salud
2018-04-01
|
Series: | Revista Peruana de Medicina Experimental y Salud Pública |
Subjects: | |
Online Access: | https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/3618 |
Similar Items
-
Vigilancia por el laboratorio de la tuberculosis resistente en menores de 15 años, Colombia, 2010 a 2015
by: Angie Paola Zabaleta, et al.
Published: (2019-06-01) -
The challenge of managing extensively drug-resistant tuberculosis at a referral hospital in the state of São Paulo, Brazil: a report of three cases
by: Marcos Abdo Arbex, et al.
Published: (2015-12-01) -
New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
by: Denise Rossato Silva, et al. -
Tuberculosis Pulmonar: reto actual para la Salud Pública cubana
by: Joel Sánchez Portela, et al. -
Implementation of a telediagnostic system for tuberculosis and determination of multi-drug resistance based in the MODS method in Trujillo, Peru
by: Luis Rodríguez, et al.
Published: (2014-09-01)